Clinical trial
tDCS to Decrease Opioid Relapse (UH3)
NCT06432465 is registered in ClinicalTrials.gov with Butler Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- tDCS to Decrease Opioid Relapse (UH3)
- Lead sponsor
- Butler Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 17, 2024
- Completion date
- December 31, 2026
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
opioid use disorder